Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY1R | P25929 | 3/20 | 0.43 |
| ▸ | GNRHR | P30968 | 11/20 | 0.39 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL8555320 | 0.85 | NPY1R (0.42) | NPY1RGNRHRDGAT2LTA4H | |
| SCHEMBL8553471 | 0.82 | NPY1R (0.46) | NPY1R | |
| Trifluoroacetic Acid SCHEMBL8554222 | 0.76 | GNRHR (0.39) | GNRHR | |
| Trifluoroacetic Acid SCHEMBL8553079 | 0.75 | NPC1 (0.38) | GNRHR | |
| Trifluoroacetic Acid SCHEMBL8552866 | 0.74 | NPY1R (0.48) | NPY1R | |
| Trifluoroacetic Acid SCHEMBL8554400 | 0.73 | NPY1R (0.44) | NPY1R | |
| Trifluoroacetic Acid SCHEMBL7693326 | 0.72 | NPY1R (0.67) | NPY1R | |
| SCHEMBL8556872 | 0.72 | NPY1R (0.44) | NPY1RDGAT2 | |
| Trifluoroacetic Acid SCHEMBL8555259 | 0.72 | RHEB (0.38) | NPY1RDGAT2 | |
| Trifluoroacetic Acid SCHEMBL8552705 | 0.72 | NPY1R (0.38) | NPY1RDGAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0871442-A1 | BENZIMIDZOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1998-10-21 | — | — | EP | disclosed |
| WO-1997025041-A1 | BENZIMIDZOLYL NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1997-07-17 | — | — | WO | disclosed |